Vici venous stent Boston Scientific has signed an agreement to acquire Veniti, a privately-held company in Fremont, California, which developed and commercialized the Vici venous stent system for treating venous obstructive disease. Boston Scientific has been an investor in Veniti since 2016 and owned 25 percent of the company. The transaction price for the
Cardiovascular Systems Inc. , medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, presented two-year outcomes from its LIBERTY 360° study in a late-breaking presentation at the 2018 Amputation Prevention Symposium (AMP) in Chicago Aug. 8. The LIBERTY 360° study is designed
Medical groups have applauded steps that the Centers for Medicare & Medicaid Services took to ease administrative burden through a new rule on hospital payments, while still pressing the agency for further changes in its approach to electronic health records. On Aug. 2, the CMS unveiled the final version of
Microsoft is developing new blood pressure monitoring technology called Glabella, which comes equipped on a pair of glasses that passively collects physiological data on the wearer, according to a research paper recently released by the company. The paper was written by Christian Holz, Microsoft Research in Redmond; and Edward J.
The third Annual Value-Based Care Summit, which will feature top executives from leading healthcare organizations sharing best practices and real-world advice for succeeding with the transition to value-based care, will be Oct. 17-19 in Boston. The Summit will kick-off with a full-day dedicated to revenue cycle management. Keynote speakers